ArticleJMIR research protocols2025
Establishing Barriers to and Enablers of Nurse-Enabled Subcutaneous Therapy Self-Administration Programs for Patients With Myeloma: Protocol for a Qualitative Descriptive Study.
Article in JMIR research protocols, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Multiple myeloma (MM) is associated with the greatest symptom burden of all hematological cancers and, despite substantial improvements in treatment options with high response and survival rates, is still considered incurable, with patients undergoing multiple lines of therapy over many years. Subcutaneous (SC) injections are a common mode of delivery for current and future MM therapy, with evidence suggesting that programs that give patients or carers responsibility for administration can bring benefits to the patient and health care system by reducing the number of required visits to hospital. Objective: This study will explore and describe barriers to and enablers of implementing nurse-enabled SC therapy self-administration programs for patients with MM to develop a road map for national scalability. Methods: This qualitative descriptive study is informed by the Consolidated Framework for Implementation Research. Participants included key stakeholders from across Australia, including patients, carers, health professionals, and policymakers with experience of implementation, facilitation, and participation in nurse-enabled SC therapy self-administration programs. Data were collected via virtual focus groups or semistructured interviews and analyzed using the framework method to identify barriers and enablers. The Expert Recommendations for Implementing Change matching tool will be used to develop strategies to target barriers and enhance enablers, informing the development of a national road map. Results: This study was funded in March 2024 and approved by Peter MacCallum Cancer Centre Human Research Ethics Committee in May 2024. Data collection was conducted between June 2024 and November 2024. A total of 32 participants were recruited. Data analysis is underway, with results expected to be published in February 2026. Conclusions: To our knowledge, this study will be the first of its kind to identify and compare barriers to and enablers of implementing nurse-enabled SC self-administration programs for patients with MM. Applying the Consolidated Framework for Implementation Research to guide study processes provides an evidence-informed approach to understanding how discrete and intersecting factors influence program implementation and sustainability, informing the development of a comprehensive implementation road map. As the availability of SC therapies grows for other cancers and chronic diseases, this model of care could serve as a blueprint for broader applications, impacting patient quality of life and optimization of health care use.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.